Respiratory syncytial virus (RSV) leads to over 30 million severe respiratory infections, 3.5 million hospitalizations, and 100,000 deaths among children under five each year globally. Nearly half of ...

Human metapneumovirus (hMPV) has been hitting the headlines recently as one of the lesser-known winter illnesses that can ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.

The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...

Illinois had at least 103 outbreaks of the stomach bug norovirus in November and December – a dramatic increase from previous ...

Surge in Hospital Admissions is Driven by Flu; IDPH Reminds Public it’s NOT too Late to get Flu, COVID-19 and RSV Shots The Illinois Department of Public Health (IDPH) announced that in line with the ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The Health Department of Northwest Michigan is reporting an increase in respiratory illnesses across Antrim, Charlevoix, ...

Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

As the colder winter weather settles in, rates of respiratory illnesses like flu, COVID-19 and RSV can rise. These infections ...